
    
      Non-interventional multicentre retrospective study using chart reviews - study was submitted
      to the ethics committee of city of Vienna - due to the design of the study no specific
      approval necessary.

      Inclusion of MDS (all subtypes and risk groups) patients according to WHO or oligoblastic AML
      (RAEB-T according to FAB), untreated and treated during their chronic MDS phase

      The 26 centers of the IWG-PM have provided control data set of untreated, all centers will be
      asked for contribution of treated patients Data will be collected in Austria, Brazil, Czech
      Republic, France, Germany, Italy, Japan, Netherlands, Spain, UK, USA.
    
  